ASP8825 - Study in Patients With Restless Legs Syndrome

NCT00530530 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

474

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: ASP8825
DRUG: Placebo

Sponsor

Astellas Pharma Inc